ERNA
Price
$0.22
Change
+$0.02 (+10.00%)
Updated
Apr 25 closing price
Capitalization
13.43M
INGN
Price
$7.28
Change
+$0.13 (+1.82%)
Updated
Apr 25 closing price
Capitalization
176.12M
9 days until earnings call
SRTS
Price
$4.74
Change
+$0.06 (+1.28%)
Updated
Apr 25 closing price
Capitalization
61.97M
3 days until earnings call
Ad is loading...

ERNA or INGN or SRTS

Header iconERNA vs INGN vs SRTS Comparison
Open Charts ERNA vs INGN vs SRTSBanner chart's image
Ernexa Therapeutics
Price$0.22
Change+$0.02 (+10.00%)
Volume$210.79K
Capitalization13.43M
Inogen
Price$7.28
Change+$0.13 (+1.82%)
Volume$172.21K
Capitalization176.12M
Sensus Healthcare
Price$4.74
Change+$0.06 (+1.28%)
Volume$27.69K
Capitalization61.97M
ERNA vs INGN vs SRTS Comparison Chart
Loading...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (ERNA: $0.22INGN: $7.28SRTS: $4.74)
Brand notoriety: ERNA, INGN and SRTS are all not notable
INGN and SRTS are part of the Medical Specialties industry, and ERNA is in the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERNA: 98%, INGN: 48%, SRTS: 18%
Market capitalization -- ERNA: $13.43M, SRTS: $61.97M, INGN: $176.12M
$INGN [@Medical Specialties] is valued at $176.12M. $SRTS’s [@Medical Specialties] market capitalization is $ $61.97M. $ERNA [@Biotechnology] has a market capitalization of $ $13.43M. The market cap for tickers in the [@Medical Specialties] industry ranges from $ $3.82T to $ $0. The market cap for tickers in the [@Biotechnology] industry ranges from $ $272.78B to $ $0. The average market capitalization across the [@Medical Specialties] industry is $ $8.34B. The average market capitalization across the [@Biotechnology] industry is $ $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERNA’s FA Score shows that 0 FA rating(s) are green whileINGN’s FA Score has 0 green FA rating(s), and SRTS’s FA Score reflects 0 green FA rating(s).

  • ERNA’s FA Score: 0 green, 5 red.
  • INGN’s FA Score: 0 green, 5 red.
  • SRTS’s FA Score: 0 green, 5 red.
According to our system of comparison, INGN and SRTS are a better buy in the long-term than ERNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERNA’s TA Score shows that 4 TA indicator(s) are bullish while INGN’s TA Score has 5 bullish TA indicator(s), and SRTS’s TA Score reflects 3 bullish TA indicator(s).

  • ERNA’s TA Score: 4 bullish, 4 bearish.
  • INGN’s TA Score: 5 bullish, 4 bearish.
  • SRTS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, INGN is a better buy in the short-term than ERNA and SRTS.

Price Growth

ERNA (@Biotechnology) experienced а +16.76% price change this week, while INGN (@Medical Specialties) price change was +6.74% , and SRTS (@Medical Specialties) price fluctuated +3.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.62%. For the same industry, the average monthly price growth was -3.92%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

ERNA is expected to report earnings on Mar 12, 2025.

INGN is expected to report earnings on Aug 12, 2025.

SRTS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+5.62% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INGN($176M) has a higher market cap than SRTS($62M) and ERNA($13.4M). INGN YTD gains are higher at: -20.611 vs. ERNA (-26.531) and SRTS (-31.503). SRTS has higher annual earnings (EBITDA): 79K vs. ERNA (-36.12M) and INGN (-58.34M). INGN has more cash in the bank: 128M vs. SRTS (23.1M) and ERNA (1.73M). ERNA has less debt than SRTS and INGN: ERNA (684K) vs SRTS (783K) and INGN (21.9M). INGN has higher revenues than SRTS and ERNA: INGN (316M) vs SRTS (24.4M) and ERNA (582K).
ERNAINGNSRTS
Capitalization13.4M176M62M
EBITDA-36.12M-58.34M79K
Gain YTD-26.531-20.611-31.503
P/E RatioN/A71.43126.00
Revenue582K316M24.4M
Total Cash1.73M128M23.1M
Total Debt684K21.9M783K
FUNDAMENTALS RATINGS
ERNA vs INGN vs SRTS: Fundamental Ratings
ERNA
INGN
SRTS
OUTLOOK RATING
1..100
101532
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
10010080
SMR RATING
1..100
1009260
PRICE GROWTH RATING
1..100
956260
P/E GROWTH RATING
1..100
10053100
SEASONALITY SCORE
1..100
50n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ERNA's Valuation (50) in the Medical Specialties industry is in the same range as INGN (50) and is in the same range as SRTS (50). This means that ERNA's stock grew similarly to INGN’s and similarly to SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as ERNA (100) and is in the same range as INGN (100). This means that SRTS's stock grew similarly to ERNA’s and similarly to INGN’s over the last 12 months.

SRTS's SMR Rating (60) in the Medical Specialties industry is in the same range as INGN (92) and is somewhat better than the same rating for ERNA (100). This means that SRTS's stock grew similarly to INGN’s and somewhat faster than ERNA’s over the last 12 months.

SRTS's Price Growth Rating (60) in the Medical Specialties industry is in the same range as INGN (62) and is somewhat better than the same rating for ERNA (95). This means that SRTS's stock grew similarly to INGN’s and somewhat faster than ERNA’s over the last 12 months.

INGN's P/E Growth Rating (53) in the Medical Specialties industry is somewhat better than the same rating for SRTS (100) and is somewhat better than the same rating for ERNA (100). This means that INGN's stock grew somewhat faster than SRTS’s and somewhat faster than ERNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ERNAINGNSRTS
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
71%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 7 days ago
63%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
72%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 7 days ago
83%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Bearish Trend 8 days ago
83%
View a ticker or compare two or three
Ad is loading...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAOSX14.200.05
+0.35%
Harbor International Core Institutional
JFNNX66.540.10
+0.15%
Janus Henderson Global Life Sciences N
TEOOX8.53N/A
N/A
Transamerica Emerging Markets Eq R6
TRMVX24.72-0.05
-0.20%
SEI Large Cap Value F (SIMT)
MGPSX68.77-0.22
-0.32%
ProFunds Mid Cap Growth Svc

ERNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERNA has been loosely correlated with CGEN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ERNA jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERNA
1D Price
Change %
ERNA100%
+5.42%
CGEN - ERNA
39%
Loosely correlated
N/A
MDGL - ERNA
36%
Loosely correlated
+2.14%
IBIO - ERNA
32%
Poorly correlated
+8.50%
SMMT - ERNA
31%
Poorly correlated
-36.06%
CYTK - ERNA
29%
Poorly correlated
+0.25%
More

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
+1.82%
VCYT - INGN
47%
Loosely correlated
+0.28%
STRRP - INGN
44%
Loosely correlated
+3.22%
OSUR - INGN
37%
Loosely correlated
-1.32%
ITGR - INGN
36%
Loosely correlated
+1.61%
MYGN - INGN
34%
Loosely correlated
+0.68%
More

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
+1.28%
LUNG - SRTS
57%
Loosely correlated
+0.58%
VAPO - SRTS
35%
Loosely correlated
N/A
BDX - SRTS
29%
Poorly correlated
+0.31%
CDNA - SRTS
28%
Poorly correlated
-0.05%
MTD - SRTS
28%
Poorly correlated
-1.23%
More